AAAAAA

   
Results: 1-9 |
Results: 9
A BIOFET ON THE BASIS OF INTACT INSECT ANTENNAE
Authors: SCHONING MJ SCHUTZ S SCHROTH P WEISSBECKER B STEFFEN A KORDOS P HUMMEL HE LUTH H
Citation: Mj. Schoning et al., A BIOFET ON THE BASIS OF INTACT INSECT ANTENNAE, Sensors and actuators. B, Chemical, 47(1-3), 1998, pp. 235-238
SAFETY COMPARISON OF GAMMAGARD S D AND GAMIMUNE-N/
Authors: BRAY GL VANTILBORG L DICKINSON M SCHROTH P SALMUN L
Citation: Gl. Bray et al., SAFETY COMPARISON OF GAMMAGARD S D AND GAMIMUNE-N/, Molecular immunology, 35(11-12), 1998, pp. 784-784
SAFETY AND IMMUNOGENICITY OF RECOMBINANT FACTOR-VIII (RECOMBINATE(TM)) IN PREVIOUSLY UNTREATED PATIENTS (PUPS) - A 6.5-YEAR UPDATE
Authors: GRUPPO R BRAY GL SCHROTH P PERRY M GOMPERTS ED
Citation: R. Gruppo et al., SAFETY AND IMMUNOGENICITY OF RECOMBINANT FACTOR-VIII (RECOMBINATE(TM)) IN PREVIOUSLY UNTREATED PATIENTS (PUPS) - A 6.5-YEAR UPDATE, Thrombosis and haemostasis, 1997, pp. 663-663
THE USE OF ROBUST REGRESSION TECHNIQUES TO OBTAIN IMPROVED COAGULATION-FACTOR HALF-LIFE ESTIMATES
Authors: LEE ML SCHROTH P BRAY G GOMPERTS ED
Citation: Ml. Lee et al., THE USE OF ROBUST REGRESSION TECHNIQUES TO OBTAIN IMPROVED COAGULATION-FACTOR HALF-LIFE ESTIMATES, Thrombosis and haemostasis, 1997, pp. 2096-2096
DETERMINATION OF INHIBITOR-RISK AFTER RECEIVING SIGNIFICANT AMOUNTS OF FACTOR-VIII CONCENTRATES
Authors: LEE ML SCHROTH P BRAY G GOMPERTS ED
Citation: Ml. Lee et al., DETERMINATION OF INHIBITOR-RISK AFTER RECEIVING SIGNIFICANT AMOUNTS OF FACTOR-VIII CONCENTRATES, Thrombosis and haemostasis, 1997, pp. 2644-2644
IN-VIVO PHARMACOKINETICS OF RECOMBINANT FACTOR-VIII (RECOMBINATE) USING ONE-STAGE CLOTTING AND CHROMOGENIC FACTOR-VIII ASSAY
Authors: LEE C OWENS D LILLEY P GIANGRANDE P COLLINS P HAY C BRAY G GOMPERTS E SCHROTH P BARROWSCLIFFE T
Citation: C. Lee et al., IN-VIVO PHARMACOKINETICS OF RECOMBINANT FACTOR-VIII (RECOMBINATE) USING ONE-STAGE CLOTTING AND CHROMOGENIC FACTOR-VIII ASSAY, Blood, 90(10), 1997, pp. 143-143
COMPLICATIONS OF HEMOPHILIA-A IN EARLY-CHILDHOOD
Authors: ALEDORT IM BRAY GL SCHROTH P PERRY MR
Citation: Im. Aledort et al., COMPLICATIONS OF HEMOPHILIA-A IN EARLY-CHILDHOOD, Blood, 88(10), 1996, pp. 1302-1302
RESULTS FORM THE RECOMBINATE(TM) (RECOMBINANT FACTOR-VIII) STUDY OF PREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-A - A 4.5-YEAR FOLLOW-UP REPORT
Authors: BRAY GL SCHROTH P LYNES M BUCKWALTER C LEE ML GOMPERTS ED
Citation: Gl. Bray et al., RESULTS FORM THE RECOMBINATE(TM) (RECOMBINANT FACTOR-VIII) STUDY OF PREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-A - A 4.5-YEAR FOLLOW-UP REPORT, Thrombosis and haemostasis, 73(6), 1995, pp. 1013-1013
TRANSIENT INHIBITORS IN RECIPIENTS OF RECOMBINANT FACTOR-VIII (R-FVIII) - A REPORT FROM THE RECOMBINATE(TM) STUDY OF PREVIOUSLY UNTREATED PATIENTS (PUPS)
Authors: GRUPPO R BRAY GL SCHROTH P GOMPERTS ED ALEDORT L
Citation: R. Gruppo et al., TRANSIENT INHIBITORS IN RECIPIENTS OF RECOMBINANT FACTOR-VIII (R-FVIII) - A REPORT FROM THE RECOMBINATE(TM) STUDY OF PREVIOUSLY UNTREATED PATIENTS (PUPS), Blood, 86(10), 1995, pp. 758-758
Risultati: 1-9 |